EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects

Matteo Ferro iD, Gennaro Musi, Michele Marchioni iD, Martina Maggi iD, Alessandro Veccia, Francesco Del Giudice iD, Biagio Barone iD, Felice Crocetto iD, Francesco Lasorsa, Alessandro Antonelli, Luigi Schips, Riccardo Autorino und 4 weitere

International Journal of Molecular Sciences · 27.02.2023 · 24 (5) · 4615

DOI: 10.3390/ijms24054615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.02.2023. Verfasst von Matteo Ferro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cancer management is challenging from diagnosis to treatment and follow-up. In cases of small renal masses and cystic lesions the differential diagnosis of benign or malignant tissues has potential pitfalls when imaging or even renal biopsy is applied. The recent artificial intelligence, imaging techniques, and genomics advancements have the ability to help clinicians set the stratification risk, treatment selection, follow-up strategy, and prognosis of the disease. The combination of radiomics features and genomics data has achieved good results but is currently limited by the retrospective design and the small number of patients included in clinical trials. The road ahead for radiogenomics is open to new, well-designed prospective studies, with large cohorts of patients required to validate previously obtained results and enter clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansArtificial IntelligenceRetrospective StudiesProspective Studies

Stichwörter der Autor:innen

artificial intelligencegenomicsmachine learningradiogenomicsradiomicsrenal cancer

Autor:innen und Institutionen

  • Department of Urology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, 20141 Milan, Italy.
  • Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio, University of Chieti, 66100 Chieti, Italy.
  • Urology Unit, SS. Annunziata Hospital, 66100 Chieti, Italy.
  • Department of Urology, ASL Abruzzo 2, 66100 Chieti, Italy.
  • Department of Maternal Infant and Urologic Sciences, Policlinico Umberto I Hospital, University of Rome, 00161 Rome, Italy.

ORCID-Profile: Matteo Ferro, Michele Marchioni, Martina Maggi, Francesco Del Giudice, Biagio Barone, Felice Crocetto, Gian Maria Busetto, Daniela Terracciano, Giuseppe Lucarelli, Octavian Sabin Tataru

Zitieren

APA

Ferro, M., Musi, G., Marchioni, M., Maggi, M., Veccia, A., Del Giudice, F., Barone, B., Crocetto, F., Lasorsa, F., Antonelli, A., Schips, L., Autorino, R., Busetto, G. M., Terracciano, D., Lucarelli, G., & Tataru, O. S. (2023). Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects. International Journal of Molecular Sciences, 24(5), 4615. https://doi.org/10.3390/ijms24054615

Vancouver

Ferro M, Musi G, Marchioni M, Maggi M, Veccia A, Del Giudice F, et al. Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects. International Journal of Molecular Sciences. 2023;24(5):4615. doi:10.3390/ijms24054615

BibTeX
@article{Ferro2023,
  author = {Ferro, Matteo and Musi, Gennaro and Marchioni, Michele and Maggi, Martina and Veccia, Alessandro and Del Giudice, Francesco and Barone, Biagio and Crocetto, Felice and Lasorsa, Francesco and Antonelli, Alessandro and Schips, Luigi and Autorino, Riccardo and Busetto, Gian Maria and Terracciano, Daniela and Lucarelli, Giuseppe and Tataru, Octavian Sabin},
  title = {Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4615},
  doi = {10.3390/ijms24054615}
}
Kostenlos starten →